Randomized, Double-blind, Placebo-controlled, Single-center, Noninferiority Trial of Ketamine Given During Sedation to Patients With Chronic Pain and Depression
Phase: PHASE4 | Sponsor: Stanford University | Compound: Ketamine
- Status
- active
- Institution
- Stanford University
- Start date
- 2025-01-28
- End date
- 2026-12-01
- Registry ID
- NCT06317636
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.